Lazard Asset Management
BEAT

Lazard Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Lazard Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,126
Closed -$51K – 2055
2020
Q3 		$51K Hold
1,126
– – ﹤0.01% 1181
2020
Q2 		$50K Sell
1,126
-145
-11% -$6.5K ﹤0.01% 1229
2020
Q1 		$48K Buy
+1,271
New +$58.5K ﹤0.01% 1195

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Lazard Asset Management's BEAT Position: Q4 2020 in Review

Lazard Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q4 2020, closing a stake of 1,126 shares — an estimated $51K sold.

Lazard Asset Management first reported a position in BEAT in Q1 2020 and held it in 3 quarters. The position peaked at $51K in Q3 2020. 238 funds tracked by Wall St. Rank hold BEAT as of Q4 2020.

  • Lazard Asset Management reported no remaining BioTelemetry, Inc. position as of Q4 2020 after selling out during the quarter.
  • Lazard Asset Management sold 1,126 BioTelemetry, Inc. shares in Q4 2020, an estimated $51K.
  • Lazard Asset Management first reported a position in BioTelemetry, Inc. in Q1 2020 and held it in 3 quarters.
  • Lazard Asset Management's BioTelemetry, Inc. position peaked at $51K in Q3 2020.
  • 238 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2020.

Based on Lazard Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.